Fairman Jeff 4
4 · Vaxcyte, Inc. · Filed Feb 8, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Exercise/Conversion
Common Stock
2021-12-20$1.79/sh+4,469$8,000→ 10,629 total - Exercise/Conversion
Stock Option (right to buy)
2021-12-20−4,469→ 53,626 totalExercise: $1.79Exp: 2027-05-17→ Common Stock (4,469 underlying)
Holdings
- 50,000(indirect: By Trust)
Common Stock
- 341,227(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The shares subject to the option are fully vested and exercisable.